Visible now
4
Public updates currently flowing through the feed.
TinyUpdate brings the most relevant updates into one calm, trustworthy stream. Scan the headlines, verify the source, and move on with your day.
Visible now
4
Public updates currently flowing through the feed.
Trusted sources
1
Fresh signals pulled from multiple approved outlets.
Trending right now
5
Top stories with strong engagement and recency.
Live feed
Concise, sourced updates ranked for fast reading. The feed stays text-first so nothing slows down the scan.
Feed view
4 updates ready to scan
Switch between fuller cards and a tighter compact rhythm without leaving the main feed.
The FDA is reassessing its criteria for what qualifies as a 'breakthrough' device. This shift aims to streamline the approval process for innovative medical technologies.
A government watchdog is calling for the FDA to finalize its guidance regarding conflicts of interest for advisory committees. This move aims to enhance transparency and integrity in the advisory process.
Eli Lilly's new obesity medication has received FDA approval, intensifying competition with Novo Nordisk. This approval marks a significant advancement in obesity treatment options available to consumers.
The FDA's perspective on peptide compounding is under scrutiny as it impacts the pharmaceutical landscape. Additionally, the ongoing conflict in Iran is affecting recruitment for clinical trials, raising concerns in the industry.
